Silvestrol, a potent anticancer agent with unfavourable pharmacokinetics: Current knowledge on its pharmacological properties and future directions for the development of novel drugs
- DOI
- 10.1016/j.biopha.2024.117047
- Published
- 2024-08
- Container
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.biopha.2024.117047,
title = {Silvestrol, a potent anticancer agent with unfavourable pharmacokinetics: Current knowledge on its pharmacological properties and future directions for the development of novel drugs},
author = {Gregorio Peron and Andrea Mastinu and Sheila I. Peña-Corona and Hector Hernández-Parra and Gerardo Leyva-Gómez and Daniela Calina and Javad Sharifi-Rad},
year = {2024},
journal = {Biomedicine \& Pharmacotherapy},
doi = {10.1016/j.biopha.2024.117047},
url = {https://doi.org/10.1016/j.biopha.2024.117047}
}RIS
TY - JOUR TI - Silvestrol, a potent anticancer agent with unfavourable pharmacokinetics: Current knowledge on its pharmacological properties and future directions for the development of novel drugs AU - Gregorio Peron AU - Andrea Mastinu AU - Sheila I. Peña-Corona AU - Hector Hernández-Parra AU - Gerardo Leyva-Gómez AU - Daniela Calina AU - Javad Sharifi-Rad PY - 2024 JO - Biomedicine & Pharmacotherapy DO - 10.1016/j.biopha.2024.117047 UR - https://doi.org/10.1016/j.biopha.2024.117047 ER -
APA
Peron, G., Mastinu, A., Peña-Corona, S. I., Hernández-Parra, H., Leyva-Gómez, G., Calina, D., & Sharifi-Rad, J. (2024). Silvestrol, a potent anticancer agent with unfavourable pharmacokinetics: Current knowledge on its pharmacological properties and future directions for the development of novel drugs. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2024.117047
Source records
- crossref · retrieved 2026-09-26T05:52:05.529Z